Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
business development
Pharma
Merck touts newly approved Winrevair as example of BD acumen
Merck touted newly approved Winrevair and what the emergence of the potential blockbuster means for the company as it faces the Keytruda LOE.
Kevin Dunleavy
Apr 25, 2024 11:06am
Life sci consulting firm Santander makes its debut
Apr 23, 2024 10:40am
Viatris still hungry for deals after pact with Idorsia: CEO
Feb 28, 2024 10:45am
BMS CEO outlines transition strategy featuring 11 brands, BD
Feb 2, 2024 11:30am
Biogen pays $7.3B to acquire Reata and newly approved Skyclarys
Jul 28, 2023 11:17am
Teva taps BeiGene's Grant to head up business development
Jul 28, 2023 10:35am